During the past decade, Louisiana Cardiology Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Louisiana Cardiology Associates" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials), "Bleeding" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Louisiana Cardiology Associates" in a lesser frequency.

Most popular intervention types in "Louisiana Cardiology Associates" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Inclisiran sodium 300 mg" (1 trials), "Left Atrial Appendage Occlusion (Amplatzer Amulet LAA Occluder)" (1 trials), "Non-Vitamin K Oral Antagonists" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Louisiana Cardiology Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Louisiana Cardiology Associates". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Louisiana Cardiology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Louisiana Cardiology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".